Proteomics in Therapeutic Areas
At creative proteomics, our mission is to accelerate the progress for disease research projects with our unparalleled analytical technology and advanced omics technology platform, to make outstanding contributions to disease diagnosis, treatment, and prognosis. This is why we are trusted by the world's leading biopharmaceutical companies and research institutions to advance their drug discovery, preclinical and clinical research projects. We have extensive experience in oncology, immunology and immune-mediated inflammatory diseases. Make full use of the infinite possibilities of scientific innovation and more than 50 diseases can be detected in one platform.

Oncology
Accelerate your oncology program using our comprehensive suite of quantitative proteomics services for large cohort clinical samples.

Inflammatory Diseases
Advance inflammatory diseases research with our integrated quantitative proteomics for Alzheimer's disease, Parkinson's, Autism, Chronic pain, etc.

Neurological Disorders
Discover of unique high throughput quantitative proteomics platform for Neurological disorders enables large-scale proteomic or phosphoproteomic analysis of brain tissue or cerebrospinal fluid.

Metabolic Diseases
Next-generation proteomics has increasing use in endocrine and metabolic diseases, including pituitary, thyroid, bone metabolic disorders, diabetes, and obesity.

Rare Disease
Reveal a deeper understanding of the underlying biology and provide actionable knowledge to accelerate and de-risk your research in rare diseases.